Skip to main navigation Skip to search Skip to main content

Australia Patent: Icahn School of Medicine at Mount Sinai Files Application for 'Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis'

Press/Media: Expert Comment

Period17 Nov 2018 → 15 Jul 2022

Media coverage

2

Media coverage

  • TitleAustralia Patent: ICahn School of Medicine at Mount Sinai Files Application for 'TARGETING THE INNATE IMMUNE SYSTEM TO INDUCE LONG-TERM TOLERANCE AND TO RESOLVE MACROPHAGE ACCUMULATION IN ATHEROSCLEROSIS'
    Media name/outletAustralian Government News (Ht Media)
    Date15/07/22
    PersonsWillem J.M. Mulder
  • TitleAustralia Patent: Icahn School of Medicine at Mount Sinai Files Application for 'Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis'
    Media name/outletAustralian Government News (Ht Media)
    Country/TerritoryAustralia
    Date17/11/18
    PersonsWillem J.M. Mulder